Ann: Proposed Acquisition of ResApp Health by Pfizer, page-287

First time you invested in a biotech start-up???? The market value the result of the COVID-19 study (not clinical trial) at 10c after over 50M shares traded on that day and the pps dropped down to 7.5c on very low volume so likely RI selling. The pps has dropped to as low as 4c due to the clinical trial results in the US nd FDA decline we all know what happened in those 3 occasions and more so the slow commercialisation of ResAppDx-EU which was finally just gaining traction last quarter.